FR2073408B1 - - Google Patents

Info

Publication number
FR2073408B1
FR2073408B1 FR7042071A FR7042071A FR2073408B1 FR 2073408 B1 FR2073408 B1 FR 2073408B1 FR 7042071 A FR7042071 A FR 7042071A FR 7042071 A FR7042071 A FR 7042071A FR 2073408 B1 FR2073408 B1 FR 2073408B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7042071A
Other versions
FR2073408A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2073408A1 publication Critical patent/FR2073408A1/fr
Application granted granted Critical
Publication of FR2073408B1 publication Critical patent/FR2073408B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7042071A 1969-11-24 1970-11-24 Expired FR2073408B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87957969A 1969-11-24 1969-11-24

Publications (2)

Publication Number Publication Date
FR2073408A1 FR2073408A1 (fr) 1971-10-01
FR2073408B1 true FR2073408B1 (fr) 1974-05-24

Family

ID=25374430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7042071A Expired FR2073408B1 (fr) 1969-11-24 1970-11-24

Country Status (15)

Country Link
US (1) US3669969A (fr)
JP (1) JPS5026560B1 (fr)
AT (1) AT310758B (fr)
BE (1) BE759337A (fr)
CA (1) CA974992A (fr)
CH (1) CH560216A5 (fr)
DE (1) DE2058185A1 (fr)
ES (1) ES385683A1 (fr)
FR (1) FR2073408B1 (fr)
GB (1) GB1322930A (fr)
IE (1) IE34676B1 (fr)
IL (1) IL35583A (fr)
NL (1) NL7017185A (fr)
SE (1) SE388617B (fr)
ZA (1) ZA707509B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963720A (en) * 1972-10-27 1976-06-15 Sandoz, Inc. Tetracyclic imidazo [2,1-b] quinazolinone derivatives
EP0008249B1 (fr) * 1978-07-28 1981-08-26 Synthelabo Dérivés de fluorènes et fluoranthènes, leur procédé de préparation et leur application en thérapeutique
DE3220438A1 (de) * 1982-05-29 1983-12-01 Troponwerke GmbH & Co KG, 5000 Köln Chinazolinonderivate, verfahren zu ihrer herstellung und ihre verwendung inn arzneimitteln
WO1989011274A1 (fr) * 1988-05-16 1989-11-30 The United States Of America, As Represented By Th Composition chimiotherapeutique pour le traitement du sida
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
EP2203049A2 (fr) * 2007-09-17 2010-07-07 The Trustees of Columbia University in the City of New York Synthèse de produits naturels à base de resvératrol
WO2011103442A2 (fr) * 2010-02-18 2011-08-25 The Trustees Of Columbia University In The City Of New York Synthèse des agents immunosuppressifs puissants, le dalesconol a et b
DE102010024542A1 (de) * 2010-06-22 2011-12-22 Merck Patent Gmbh Materialien für elektronische Vorrichtungen
CN107573363A (zh) * 2012-09-20 2018-01-12 Udc 爱尔兰有限责任公司 供电子应用的氮杂二苯并呋喃和包含氮杂二苯并呋喃的电子器件
CN112010925B (zh) * 2019-05-28 2021-10-26 首都医科大学 Gde及羟甲基修饰的苯并咪唑喹唑啉，其合成，活性和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244717A (en) * 1964-06-18 1966-04-05 Searle & Co 5-hydroxy-2-methyl-7-phenylimidazo [1, 2-a] pyrimidines
US3501473A (en) * 1967-11-09 1970-03-17 American Home Prod Disubstituted - 11h - quinazolino - (2,3-b) quinazoline - 11,13 (5h) - diones and the process for their preparation

Also Published As

Publication number Publication date
IE34676B1 (en) 1975-07-09
SE388617B (sv) 1976-10-11
BE759337A (fr) 1971-05-24
IL35583A (en) 1975-02-10
ES385683A1 (es) 1973-10-01
JPS5026560B1 (fr) 1975-09-01
CH560216A5 (fr) 1975-03-27
IL35583A0 (en) 1971-01-28
GB1322930A (en) 1973-07-11
DE2058185A1 (de) 1971-06-03
US3669969A (en) 1972-06-13
IE34676L (en) 1971-05-24
CA974992A (en) 1975-09-23
FR2073408A1 (fr) 1971-10-01
AT310758B (de) 1973-10-10
NL7017185A (fr) 1971-05-26
ZA707509B (en) 1971-08-25

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
JPS5026560B1 (fr)
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU442463B2 (fr)
AU414607B2 (fr)
AU428129B2 (fr)
AU428131B2 (fr)
AU425297B2 (fr)
AU442380B2 (fr)
AU438128B2 (fr)
AT308690B (fr)
AU442285B2 (fr)
AU442322B2 (fr)
AU442357B2 (fr)
AU417208B2 (fr)
AU470661B1 (fr)
AU410358B2 (fr)
AU442535B2 (fr)
AU442538B2 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse